↓ Skip to main content

Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer

Overview of attention for article published in Journal of Translational Medicine, June 2009
Altmetric Badge

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer
Published in
Journal of Translational Medicine, June 2009
DOI 10.1186/1479-5876-7-49
Pubmed ID
Authors

Heather L Pulaski, Gregory Spahlinger, Ines A Silva, Karen McLean, Angela S Kueck, R Kevin Reynolds, George Coukos, Jose R Conejo-Garcia, Ronald J Buckanovich

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 38 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 26%
Researcher 8 21%
Student > Bachelor 4 10%
Other 2 5%
Student > Master 2 5%
Other 5 13%
Unknown 8 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 21%
Biochemistry, Genetics and Molecular Biology 7 18%
Medicine and Dentistry 6 15%
Immunology and Microbiology 3 8%
Computer Science 2 5%
Other 4 10%
Unknown 9 23%